Previous Article | Next Article ![]()
Applied and Environmental Microbiology, June 2002, p. 2699-2703, Vol. 68, No. 6
0099-2240/02/$04.00+0 DOI: 10.1128/AEM.68.6.2699-2703.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Institute for Microbial and Biochemical Technology, USDA Forest Products Laboratory, Madison, Wisconsin 53705
Received 8 January 2002/ Accepted 5 March 2002
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Recent work has shown that the brown-rot basidiomycete Gloeophyllum trabeum has such a mechanism (12, 14, 18). This fungus secretes 2,5-dimethoxyhydroquinone and 4,5-dimethoxycatechol, both of which reduce extracellular Fe3+. These one-electron oxidoreductions generate semiquinone radicals, which reduce either Fe3+ or O2 in a second one-electron step that produces 2,5-dimethoxy-1,4-benzoquinone (2,5-DMBQ) and 4,5-dimethoxy-1,2-benzoquinone (4,5-DMBQ). G. trabeum then reduces these quinones to regenerate the hydroquinone and catechol that are needed to produce additional Fenton reagent. A similar redox cycle may contribute to biodegradation by some white-rot fungi (9).
It is unclear how G. trabeum reduces the quinones that it produces; indeed, almost nothing is known about biodegradative enzymes in this highly destructive fungus. In this study we characterized the major quinone reductase, as well as the gene and mRNA that encode this enzyme, from G. trabeum cultures that express high levels of hydroquinone biosynthesis and extracellular Fenton chemistry.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Reagents.
4,5-DMBQ was prepared by oxidizing and methylating phenol as described previously (12, 19). 2,5-DMBQ was purchased from TCI America (Portland, Oreg.). Other chemicals, all reagent grade, were obtained from Sigma/Aldrich or Pharmacia.
Production of extracellular quinones by G. trabeum.
Each assay was done in triplicate as follows. The extracellular medium from three cultures of the same age was pooled, oxidized by adding FeCl3 to a final concentration of 0.1 mM, and at filtered. A portion of the sample was then assayed for 2,5-DMBQ and 4,5-DMBQ by high-performance liquid chromatography (HPLC) as described previously (12).
Reduction of quinones by G. trabeum.
Each assay was done in triplicate as follows. Three G. trabeum mycelial mats of the same age were placed in a glass vial that contained 2,6-dimethoxy-p-benzoquinone (2,6-DMBQ) or 2,5-DMBQ (250 µM) in 20 ml of 25 mM sodium oxalate (pH 4.0). The solution was recirculated through a 1-cm-path-length quartz flow cell at a rate of 6 ml/min and at the ambient temperature. The decrease in absorbance of the solution was monitored at 394 nm for 2,6-DMBQ (
= 0.64 mM-1 cm-1) and at 380 nm for 2,5-DMBQ (
= 0.31 mM-1 cm-1). Previous work has shown that very little of the quinone is taken up by the mycelium in such experiments and therefore that the decrease in visible absorbance serves as a reliable measure of quinone reduction (12, 14).
Subcellular fractionation of quinone reductase activity.
The mycelial mats from 12 Fernbach cultures were harvested on day 7, collected by filtration through miracloth, and rinsed with ice-cold Milli-Q water. All subsequent steps were done at 0 to 4°C. The mycelium was combined with 150 ml of homogenization buffer, which consisted of 50 mM sodium citrate (pH 6.0), 300 mM sucrose, 5 mM EDTA, 5 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, and 1 mM benzamidine. The mixture was disrupted three times for 1 min with a 10-min cooling period between bursts by using an ice-jacketed glass bead homogenizer (Bead-Beater; Biospec Products, Bartlesville, Okla.). The homogenate was centrifuged for 20 min at 10,000 x g to remove mitochondria and cell wall material, and the supernatant fraction was retained. A measured portion of the supernatant fraction was ultracentrifuged for 60 min at 100,000 x g to separate the soluble fraction from the crude microsomal fraction, and the microsomal pellet was resuspended in 50 mM sodium citrate (pH 6.0) that contained 300 mM sucrose and 5 mM KCl. The three fractions were assayed for quinone reductase activity as described below.
Enzyme purification.
All enzyme purification steps were done at 0 to 5°C unless stated otherwise. The mycelial mats from 25 Fernbach cultures were harvested on day 7 as described above and frozen for 1 h at -75°C. The frozen mycelium was suspended in 150 ml of buffer that contained 100 mM sodium citrate (pH 6.0), 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, and 1 mM benzamidine. The mixture was homogenized as described above, and the glass beads were rinsed with additional buffer to give about 200 ml of crude extract.
The extract was centrifuged at 14,000 x g for 20 min, and the supernatant fraction was loaded on a column of Phenyl Sepharose 6 (fast flow grade; 18.5 by 2.5 cm; Sigma) that had been equilibrated beforehand with 100 mM sodium citrate (pH 6.0). The column was washed with 200 ml of 100 mM sodium citrate (pH 6.0) and then with a 600-ml linear gradient that began with 100 mM sodium citrate (pH 6.0) and ended with 70% ethylene glycol in 10 mM sodium citrate (pH 6.0). The NADH:quinone reductase activity eluted in a single peak at an ethylene glycol concentration of about 45%. The active fractions were concentrated by ultrafiltration and dialyzed under a vacuum in a collodion bag apparatus (10-kDa cutoff) against 20 mM sodium citrate (pH 6.0) that contained 20% (vol/vol) ethylene glycol. The final volume was less than 100 µl.
This sample was brought to a volume of 10 ml with 20 mM sodium phosphate (pH 6.0) and was immediately applied to a preequilibrated 2-ml column of hydroxyapatite (Macroprep Ceramic type 1; particle size, 8 µm; Bio-Rad) that was then washed with the same phosphate buffer. The quinone reductase activity eluted in this passthrough fraction, which was immediately dialyzed against 20 mM citrate buffer-20% ethylene glycol and concentrated as described above. Any delay in the removal of phosphate resulted in an increased loss of enzyme activity.
The enzyme preparation was brought to a volume of about 7 ml in 10 mM sodium phosphate buffer (pH 6.0) and was immediately applied to a column of DEAE Sepharose (9.0 by 1.0 cm; Pharmacia) that had been equilibrated beforehand with the same buffer. The column was washed with 20 ml of this buffer and then with a 100-ml linear gradient from 10 to 100 mM sodium phosphate (pH 6.0). The NADH:quinone reductase activity eluted in a single peak at a phosphate concentration of about 40 mM. The recovered enzyme was immediately concentrated and dialyzed against 20 mM citrate buffer-20% ethylene glycol in the collodion bag apparatus. Use of phosphate as the eluant salt in this step resulted in some loss of activity but was unavoidable because the reductase did not adhere to the column reproducibly when other salts, such as chloride or acetate, were used.
The enzyme sample (approximately 300 µl) was further purified by gel permeation chromatography on a column of Superdex 200 (30.0 by 1.0 cm; Pharmacia), which was operated on a Pharmacia fast-performance liquid chromatography apparatus in 100 mM sodium citrate (pH 6.0) at room temperature and was calibrated with a protein molecular weight standard kit (Pharmacia). The NADH:quinone reductase eluted in a single peak. It was concentrated and dialyzed against 20 mM citrate (pH 6.0) that contained 20% ethylene glycol and was stored at -20°C.
Enzyme and protein assays.
For routine assays of quinone reduction, it was most convenient to use 2,6-DMBQ as the acceptor instead of 2,5-DMBQ or 4,5-DMBQ. 2,5-DMBQ dissolves slowly in water, which makes stock solutions difficult to prepare, and 4,5-DMBQ is not commercially available.
NAD(P)H:quinone reductase activity was assayed spectrophotometrically by monitoring the decrease in absorbance at 340 nm due to NAD(P)H oxidation (
340 = 6.2 mM-1 cm-1). The amount of enzyme that catalyzed the oxidation of 1 µmol of NADH/min was defined as 1 U of activity. The standard 2.0-ml assay mixture contained enzyme, sodium citrate (50 mM, pH 6.0), NAD(P)H (200 µM), and quinone (100 µM). The reactions were conducted in magnetically stirred 1-cm-path-length cuvettes that were maintained at 25°C. For Michaelis-Menten experiments, the substrate concentrations were varied as required and each assay was done in quadruplicate. The standard deviations for the rates in replicate assays were ±5% or less.
The same assay was used to look for sugar oxidases that use quinones as alternate electron acceptors, except that glucose (200 µM) replaced NAD(P)H, and the reduction of 2,6-DMBQ was monitored directly at 394 nm. Glucose oxidase activity was also assayed with O2 as the acceptor by using a coupled colorimetric assay with horseradish peroxidase and 2,2'-azino-bis-(3-ethylbenzthiazoline-6-sulfonic acid) (15).
To determine the stoichiometry of quinone reduction by the G. trabeum quinone reductase, the amount of hydroquinone produced was determined by HPLC as described previously (12). Protein was assayed with a Coomassie blue dye binding assay (Bio-Rad), which was standardized with bovine serum albumin. Purified quinone reductase was also quantitated from its absorbance at 450 nm due to flavin mononucleotide (FMN) (
= 12.2 mM-1 cm-1), assuming two FMN molecules per enzyme molecule and a subunit molecular weight of 22,000. With purified G. trabeum quinone reductase, the two methods gave values that agreed within less than 10%.
Physical characterization of the quinone reductase.
The UV-visible absorption spectrum of the purified enzyme (0.2 mg/ml) was recorded in 20 mM sodium citrate (pH 6.0) that contained 20% ethylene glycol.
Flavin was extracted from G. trabeum quinone reductase by boiling a sample for 10 min. Because flavin adenine dinucleotide (FAD) can be hydrolyzed to FMN, a control sample of the FAD-containing glutathione reductase from Saccharomyces cerevisiae was also boiled, as were authentic standards of FAD and FMN. These controls established that FAD was not hydrolyzed under our extraction conditions and that the recovery of both flavins for analysis was nearly quantitative. The samples were analyzed by HPLC using external FAD and FMN standards. The column (Phenylhexyl Luna; 150 by 4.6 mm; particle size, 5 µm; Phenomenex) was operated in water-acetonitrile-formic acid (87.5:12.5:0.1) at a rate of 1.0 ml/min and at the ambient temperature. FAD eluted at 6 min, and FMN eluted at 10 min.
Sodium dodecyl sulfate (SDS) gel electrophoresis and analytical isoelectric focusing of the purified quinone reductase were done with precast polyacrylamide gels in a Pharmacia Phast System apparatus. The gels were calibrated with protein standard kits from Pharmacia and were stained with Coomassie blue R250.
Tryptic digestion, mass spectral analysis, and internal Edman sequencing of the reductase were done at the Keck Foundation Biotechnology Resource Laboratory at Yale University. Samples were prepared as outlined on the Keck website (http://info.med.yale.edu/wmkeck).
Isolation of cDNA and genomic clones.
To obtain RNA, mycelial pellets were snap frozen in liquid nitrogen, and the poly(A) RNA was purified by magnetic capture with oligo(dT)15 Dynabeads (Dynal, Great Neck, N.Y.) used according to the manufacturer's recommendations. RNA was stored as an ethanol precipitate at -20°C. To obtain total genomic DNA, pellets from log-phase cultures were extracted as described previously (20).
Experimentally determined peptide sequences were used to design two degenerate primers, 5'-AAXGTXCCXGCXCCCCAXGG-3' and 5'-AAYTAYCAYCGXTTYYTXTT-3'. Poly(A) RNA was reverse transcribed with oligo(dT) and used as a template in 50-µl PCR mixtures with 50 to 150 pmol of degenerate primer. The reaction cycles were as follows: 94°C for 6 min, 58°C for 2 min, and 72°C for 40 min for one cycle, followed by 94°C for 1 min, 58°C for 2 min, and 72°C for 5 min for 35 cycles and finally an extension step consisting of 72°C for 15 min. Several reaction mixtures were pooled, and a 300-bp fragment was subcloned into pGEM-T (Promega Biotech, Madison, Wis.). Nucleotide sequences were determined by using an ABI Prism Big Dye terminator cycle sequencing kit (PE Applied Biosystems, Foster City, Calif.) with an ABI377 DNA sequencer.
From the partial cDNA sequence, cloning was extended into the flanking genomic sequence by using a Universal genome walking kit (Clonetech Laboratories, Palo Alto, Calif.) with the following primers: 5'-CGTTCTGGGACTCCACTGGTCCCCTCT-3' and 5'-AAACGAAGAGACCCGCGTACTTGCCG-3'. Several extension products were subcloned and sequenced. Based on the extended genomic sequences, primers 5'-AGACGCAGCGGGCGTAATG-3' and 5'-GAGACGCCACGCAGTTTACC-3' were designed to PCR amplify the full-length cDNA and corresponding genomic clones with a high-fidelity polymerase, Pfu (Stratagene, La Jolla, Calif.). Sequences were analyzed and compared by using DNASTAR software (DNASTAR, Madison, Wis.).
Nucleotide sequence accession numbers.
The G. trabeum genomic and cDNA sequences have been deposited in the GenBank database under accession numbers AF465405 and AF465406, respectively.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
|
Kinetic parameters of the reductase.
We did Michaelis-Menten experiments at pH 6.0 with the two physiological quinones, 2,5-DMBQ and 4,5-DMBQ. Each experiment was done two or three times, and all of the results yielded linear Lineweaver-Burk plots, which showed that the Km for both 2,5-DMBQ and 4,5-DMBQ was 5 to 7 µM, whereas the Km for NADH was 85 to 90 µM. Estimation of the enzyme's kcat gave values between 1,100 and 1,600 s-1. These Km and kcat values are subject to considerable error, because the enzyme's extremely high affinity for quinones required us to measure small absorbance changes during the kinetics experiments. Nevertheless, the results show that the catalytic efficiency (kcat/Km) of the enzyme for 2,5-DMBQ and 4,5-DMBQ is very high, greater than 108 M-1 s-1.
Inferred amino acid sequence of the reductase.
Attempted N-terminal analyses of the reductase yielded no data, and therefore the N terminus of the mature 22-kDa protein is probably blocked. However, tryptic digestion followed by HPLC separation and Edman degradation of selected peptides yielded three internal sequences: NYDGFLFGIPTR, GGSPWGAGTFANSDGSR, and SFYEYVAR.
We used degenerate primers based on portions of these peptide sequences to amplify cDNA from G. trabeum cultures that expressed high levels of quinone reductase activity. We sequenced the resulting cDNA clone and found that it contained nucleotide sequences that exactly matched the three experimentally determined peptide sequences. A comparison of the G. trabeum cDNA sequence with related sequences in the GenBank database showed that the SFYEYVAR peptide, in particular, is located in a highly variable region near the C terminus of the quinone reductase. Therefore, the probability is very high that the cDNA which we isolated corresponds to the enzyme which we purified.
The G. trabeum quinone reductase (accession number AAL67860; see the GenBank database) is similar to a protein expressed by Paracoccidioides brasiliensis (AAL50803; 66% identical) (5), to a protein encoded by the S. cerevisiae PST2 gene (CAA98854; 64% identical), and to a previously reported quinone reductase from the white-rot basidiomycete Phanerochaete chrysosporium (AAD21025; 56% identical) (1). The G. trabeum reductase also exhibited lower levels of similarity with some other known and putative quinone reductases from fungal and plant sources (16), including one encoded by a minor allergen gene of Arabidopsis thaliana (CAB16805; 42% identical).
Although we were unable to identify the N terminus of the G. trabeum reductase, the data suggest two possibilities. One is that translation of the mRNA starts with Met-55 of the sequence which we submitted (AAL67860), thus yielding a 21.9-kDa mature protein without posttranslational processing. However, it seems more likely that translation starts with Met-1 to give a 27.7-kDa precursor and that a leader sequence is then cleaved from the mature protein at an unknown location near Met-55. We draw this conclusion because putative leader sequences also occur in the mRNAs for the P. chrysosporium quinone reductase (1) and the A. thaliana allergen. The function of these leaders is unclear, but all three of them are hydrophilic, and the inferred N termini of the two fungal sequences exhibit substantial similarity.
| DISCUSSION |
|---|
|
|
|---|
However, an alternative (or perhaps additional) function for the G. trabeum reductase cannot be ruled out yet. This enzyme belongs to a widely distributed family of flavoprotein quinone reductases that are generally thought to detoxify intracellular quinones by maintaining them in the reduced form (16). Quinones are cytotoxic in part because they readily undergo intracellular one-electron reduction to semiquinones, which react rapidly with O2 to produce superoxide. By contrast, hydroquinones are relatively nontoxic because they undergo rapid one-electron oxidation to semiquinones only in the presence of transition metal oxidants, such as Fe3+, which are generally unavailable inside cells because they are sequestered in redox-inactive complexes (10). Since G. trabeum produces large amounts of quinones as natural metabolites (12, 14, 18), it may have an unusually high requirement for a quinone detoxification system.
Much of the current impetus for a better understanding of brown-rot mechanisms is aimed at devising better ways to inhibit wood decay. Approximately 10% of all trees cut in the United States go to replace decayed wood, and to minimize the losses, wood rot fungi are currently controlled with toxic, environmentally deleterious biocides, such as creosote, pentachlorophenol, and chromated copper arsenate (22). It would be advantageous to target these fungi with compounds that interfere more specifically with wood decay mechanisms. Given the importance of quinone metabolism in brown rot (8, 12, 14, 18) and white rot (1, 3, 4, 9), fungal quinone reductases that drive Fenton chemistry or prevent toxicity from quinones are potential targets that merit further investigation.
| ACKNOWLEDGMENTS |
|---|
This work was supported by U.S. Department of Energy grant DE-FG02-94ER20140 to K.E.H.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | Microbiol. Mol. Biol. Rev. | Eukaryot. Cell | All ASM Journals |
|---|